Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial

Richards, D.A.; Ekers, D.; McMillan, D.; Taylor, R.S.; Byford, S.; Warren, F.C.; Barrett, B.; Farrand, P.A.; Gilbody, S.; Kuyken, W.; O'Mahen, H.; Watkins, E.R.; Wright, K.A.; Hollon, S.D.; Reed, N.; Rhodes, S.; Fletcher, E.; Finning, K.

doi:10.1016/s0140-6736(16)31140-0

All Outputs (1)

Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial (2016)
Journal Article
Richards, D., Ekers, D., McMillan, D., Taylor, R., Byford, S., Warren, F., …Finning, K. (2016). Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial. The Lancet, 388(10047), 871-880. https://doi.org/10.1016/s0140-6736%2816%2931140-0

Background Depression is a common, debilitating, and costly disorder. Many patients request psychological therapy, but the best-evidenced therapy—cognitive behavioural therapy (CBT)—is complex and costly. A simpler therapy—behavioural activation (BA)... Read More about Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial.